About QuVa Pharma
QuVa Pharma is a Healthcare company based in Sugar Land (United States) founded in 2015. Sterile compounding pharmacy services. QuVa Pharma has raised $15 million across 4 funding rounds from investors including SVB, Bain Capital Private Equity and Oxford Finance. QuVa Pharma has completed 1 acquisition, including LogicStream. QuVa Pharma offers products and services including Compounded Sterile Preparations and Featured Medical Products. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
QuVa Pharma provides the platform for sterile compounding pharmacy services. It supplies vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. It acquired the assets of the Unique Pharmaceuticals including 503B Compounding Pharmacy Services (Division of Healix) which provides ready-to-use compounded sterile preparations to hospitals. It provides specialty admixtures in IV bags (LVPs and piggy-backs), syringes, cassette and in specialized PCA vials.
- Headquarters Sugar Land, United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website quvapharma.com
- Social LinkedIn X
- Legal Name Quva Pharma
- Total Equity Funding$15M (USD)
in 4 rounds
- Latest Funding Round$41M (USD), Debt – Venture
Jul 2018
- InvestorsSVB
& 3 more
- Investments & Acquisitions
Products & Services of QuVa Pharma
QuVa Pharma offers a comprehensive portfolio of products and services, including Compounded Sterile Preparations and Featured Medical Products.
Compounded sterile preparations are supplied by QuVa Pharma for medical fields including anesthesia and pain management, ensuring compliance with quality standards
Featured medical products such as syringes and gels are offered by QuVa Pharma in ready-to-administer formats, supporting efficient healthcare delivery
Funding Insights of QuVa Pharma
QuVa Pharma has successfully raised a total of $15M across 4 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $41 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 4
- Last Round Debt – Venture — $41M
- Investors Count 4
All 4 funding rounds of QuVa Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | $41M | Debt – Venture | – | – | |
| Jan 2018 | $25M | Debt – Venture | – | – | |
| Jan 2018 | $15M | Series A | – | – | |
| Aug 2015 | Seed | – | – |
4 investors in total: 4 institutional.
Investors in QuVa Pharma
QuVa Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Bain Capital Private Equity and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Customized lease financing solutions are offered by Farnam Street Financial. | 2000 | farnamstreet.net | Minnetonka, United States | |
Private investment firm managing assets and expanding into equity, credit, and real estate services. | 1984 | baincapitalprivateequity.com | London, United Kingdom | |
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States |
Investor details for QuVa Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of QuVa Pharma
52 people are tracked at QuVa Pharma (28 in leadership, 24 in team).
| Name | Role | Group |
|---|---|---|
Varsha Gaitonde | VP, Pharmacy Services | Leadership |
Stuart Hinchen | Co-Founder & CEO | Leadership |
David Short | Chief Quality Officer | Leadership |
Jim Schmidt | Director Of Strategic Accounts | Leadership |
Mike Scouvart | Chief Commercial Officer | Leadership |
Ray Milnes | VP, Sales | Leadership |
Peter Jenkins | Co-Founder & Chief Development Officer | Leadership |
Donna Kohut | VP, Strategic Projects | Leadership |
Johnny Blackthorn White | Senior Director, Corporate Technical Operations | Leadership |
Ryan Sullivan | Chief Legal Officer, General Counsel And Secretary | Leadership |
Kat Caminiti Mba, Fache | Director Of National Accounts | Leadership |
Mike Rutkowski | VP, Quality Compliance Office | Leadership |
Manon Kebodeaux | Chief Human Resources Officer | Leadership |
Rob Hinchen | Director Commercial Operations | Leadership |
Dennis Harris | Chief Transformation Officer | Leadership |
Scott Haddon | National Account Director | Leadership |
Michael Scouvart | Chief Commercial Officer (cco) | Leadership |
Francesca R. | Director Of Strategic Accounts | Leadership |
Mahindra Anmolsingh | Director, Corporate Quality Systems/quality Validation | Leadership |
Alicia Ashford-Brown | Strategic Projects Director | Leadership |
32 more people are available in the full profile.
Complete people profiles for QuVa Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QuVa Pharma
QuVa Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include LogicStream.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical decision support is optimized for healthcare through EHR solutions. | logic-stream.net | Minneapolis, United States | 2013 | Jul 2024 | •••• |
Complete acquisition details for QuVa Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of QuVa Pharma
4 dated milestones of QuVa Pharma across 9 years, from founding to its latest funding, stage changes and deals.
- Founded QuVa Pharma is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Venture, of $41.0M.
- Acquisition Acquires LogicStream.
Web traffic of QuVa Pharma
The website of QuVa Pharma (quvapharma.com) receives about 2.2K visits a month and ranks #6,121,719 among all websites worldwide, #6,426 in Biotechnology and Pharmaceuticals.
- Monthly visits2.2K
▲ 18.1% vs previous month
- Global rank#6,121,719
among all websites
- Category rank#6,426
Health · Biotechnology and Pharmaceuticals
- Bounce rate28%
- Pages per visit3.6
- Average visit1 min 51 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with QuVa Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rxrelief.com | 100% | #2,023,097 | View details | ||
fvi.edu | fvi.edu | 66% | #2,116,463 | – | |
| pharmalogistics.com | 64% | #2,603,986 | View details | ||
quvajobs.com | quvajobs.com | 30% | – |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as QuVa Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quva Pharma
Complete news archive for QuVa Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QuVa Pharma
QuVa Pharma was founded in 2015.
QuVa Pharma is headquartered in Sugar Land, United States. It is registered at Sugar Land, Texas, United States.
QuVa Pharma is a funded company, having raised a total of $15M across 4 funding rounds to date.
QuVa Pharma provides the platform for sterile compounding pharmacy services. It supplies vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. It acquired the assets of the Unique Pharmaceuticals including 503B Compounding Pharmacy Services (Division of Healix) which provides ready-to-use compounded sterile preparations to hospitals. It provides specialty admixtures in IV bags (LVPs and piggy-backs), syringes, cassette and in specialized PCA vials.
QuVa Pharma offers Compounded Sterile Preparations and Featured Medical Products.
QuVa Pharma has made 1 acquisition, including LogicStream.
QuVa Pharma has 4 investors. Key investors include SVB, Bain Capital Private Equity, Oxford Finance, and Farnam Street Financial.
QuVa Pharma operates through Quva Pharma.